ライフサイエンスコーパス: intravenous bolus

1 y an acute amphetamine challenge (0.3 mg/kg, intravenous bolus).

2 haride (24-hr infusion) or Escherichia coli (intravenous bolus).

3 inistered 15 min before balloon injury as an intravenous bolus.

4 fectiveness of primary PCI compared with the intravenous bolus.

5 l saline (1 mL/kg/hr) (n=10 each) without an intravenous bolus.

6 her as continuous intravenous infusion or as intravenous boluses.

7 both phases, IB-MECA was administered as an intravenous bolus (100 micrograms/kg) 10 minutes before

8 Patients were randomly assigned to an intravenous bolus (180 microgram/kg) and 72-hour infusio

9 th DEX, an alpha-2 adrenergic agonist, as an intravenous bolus (2 mug per kilogram of body weight) ov

10 Five minutes before LAD reopening, an intravenous bolus (5 mg/kg) of LU 135252 was given in 10

11 Intravenous bolus (50 mL/kg) of slurry or chilled 1.5% N

12 abciximab compared with those randomized to intravenous bolus (9.2% vs. 17.6%; hazard ratio [HR]: 0.

13 Whole-body PBR images were acquired after intravenous bolus administration of (11)C-PBR28 in 7 hea

14 ve hepatic CT angiograms were obtained after intravenous bolus administration of 150-180 mL of nonion

15 is preliminary case series suggests that the intravenous bolus administration of 23.4% saline reduces

16 Intravenous bolus administration of 30 mL of 23.4% salin

17 nts of regional brain activity following the intravenous bolus administration of [15O]H2O as they alt

18 e were randomized to either intracoronary or intravenous bolus administration of eptifibatide.

19 oshiba, Aquilion 64, Japan) before and after intravenous bolus administration of iodinated non ionic

20 pain(7)(,)(8) and demonstrate that a single intravenous bolus administration of psilocybin can atten

21 ctive at doses lower than those required for intravenous bolus administration.

22 After intravenous bolus administrations of glucose tracers, ti

23 MI-4983 administered as a 5, 10, or 20 mg/kg intravenous bolus along with a 10 mg/kg/hr continuous in

24 to administration of ketamine (0.26 mg/kg by intravenous bolus and 0.65 mg/kg per hour by intravenous

25 during stent deployment as a weight-adjusted intravenous bolus and 12-hour infusion at the discretion

26 s that a) hypertonic saline when given as an intravenous bolus and continuous infusion attenuates wat

27 and anesthetized with fentanyl (10 microg/kg intravenous bolus and then 50 microg.kg(-1).hr(-1) infus

28 fluorouracil (425 mg per square meter as an intravenous bolus) and leucovorin (20 mg per square mete

29 fluorouracil (500 mg per square meter as an intravenous bolus), and leucovorin (20 mg per square met

30 roup received the recommended initial 300-mg intravenous bolus, and amiodarone was administered an av

31 (11)C-CUMI-101 was injected as an intravenous bolus, and emission data were collected for

32 .16 mCi) of 11C-CUMI-101 were injected as an intravenous bolus, and emission data were collected for

33 Chlorzoxazone was administered as an intravenous bolus, and plasma concentrations were analyz

34 (111)In-DTPA-folate was administered as an intravenous bolus, and whole-body images were obtained a

35 Intravenous bolus application of PFC (0.14 g/kg, approxi

36 selective A(2A) agonist that is given as an intravenous bolus at a fixed dose, with less undesirable

37 her atropine (0.2 mg) or saline was given by intravenous bolus at the time of induction.

38 istered uniformly (10:1 mg/m(2) ratio) as an intravenous bolus before doxorubicin.

39 Dexrazoxane was given as an intravenous bolus before each doxorubicin dose.

40 Rituximab plus intravenous bolus chemotherapy is a standard treatment f

41 reated in a standardized protocol of monthly intravenous bolus CYC were offered treatment with GnRH-a

42 vincristine plus oral prednisone followed by intravenous bolus cyclophosphamide given every 21 days f

43 and leucovorin (20 mg per square meter as an intravenous bolus) daily for five consecutive days every

44 and received cyclophosphamide 750 mg/m(2) by intravenous bolus day 1, doxorubicin 12.5 mg/m(2)/d and

45 mg/m2 day 1, and fluorouracil [FU] 200 mg/m2 intravenous bolus days 1 to 5) with or without LV (LV 20

46 Patients received regadenoson as a rapid intravenous bolus dose of 400 microg (n = 18) or 500 mic

47 29.6 +/- 6.6 kg/m(2)) received an identical, intravenous bolus dose of [1-(14)C]oleate followed by ti

48 740 MBq/m2, followed 24 h later with a fixed intravenous bolus dose of doxorubicin (60 mg/m2).

49 Intravenous bolus dose, when given, and diltiazem infusi

50 Intravenous bolus doses of insulin were administrated to

51 by lowering and raising blood pressure with intravenous bolus doses of sodium nitroprusside and phen

52 icrog/kg) of up to two identical tecadenoson intravenous bolus doses were administered.

53 ) and doxorubicin (45 mg/m2) administered by intravenous bolus every 21 days.

54 Intravenous bolus fluorouracil plus leucovorin is the st

55 1:1 ratio to receive bivalirudin (0.75 mg/kg intravenous bolus followed by 1.75 mg/kg per h infusion;

56 ived a fixed dose of FU 600 mg/m2 as a rapid intravenous bolus followed by 10 doses of PN401 given at

57 that administering flavopiridol by a 30-min intravenous bolus followed by a 4-h continuous intraveno

58 Flavopiridol, when administered by a 30-min intravenous bolus followed by a 4-h continuous intraveno

59 In rats without neuro-injury that received intravenous bolus followed by a continuous infusion, lun

60 ere anesthetized with 5 mg/kg of propofol by intravenous bolus followed by a maintenance infusion at

61 PB2452 administered as an initial intravenous bolus followed by a prolonged infusion (8, 1

62 12 IU/kg/h) plus eptifibatide (180 microg/kg intravenous bolus followed by an infusion of 1.0-2.0 mic

63 control of unfractionated heparin (60 IU/kg intravenous bolus followed by an infusion of 12 IU/kg/h)

64 00) or heparin plus a GPI (control; 60 IU/kg intravenous bolus followed by boluses with target activa

65 n during both the acute phase (initial 30 mg intravenous bolus followed by injections of 1.0 mg/kg ev

66 o received abciximab (0.25 mg/kg body weight intravenous bolus, followed by a 12-h infusion at 10 mic

67 re randomly assigned to receive a fixed-dose intravenous bolus, followed by a 72-hour infusion of pla

68 er rhIL-1ra (100 mg) or placebo (vehicle) by intravenous bolus, followed by a 72-hr continuous intrav

69 hydration strategies: oral rehydration, plus intravenous boluses for shock; a rapid intravenous strat

70 peptide mass of NESP were compared following intravenous bolus in 11 stable peritoneal dialysis patie

71 normal human donor plasma was infused as an intravenous bolus in 7 healthy adult human volunteers at

72 g/kg) was administered to all subjects as an intravenous bolus in the contralateral arm at the midpoi

73 ntravenous infusion is better tolerated than intravenous boluses in the treatment of type 1 HRS.

74 in as continuous intravenous infusion versus intravenous boluses in the treatment of type 1 HRS.

75 g intravenous bolus), or CGS 19755 (40 mg/kg intravenous bolus) in a randomized fashion.

76 rformed a 60-h endotoxemia protocol (3 ng/kg intravenous bolus) in healthy adults (n = 20, 50% male,

77 followed by 1 week rest; mitomycin 10 mg/m2 intravenous bolus infusion every 6 weeks for a total of

78 uman IL-15 (rhIL-15) administered as a daily intravenous bolus infusion for 12 consecutive days in pa

79 nesthetized rats were randomized to a 15-min intravenous bolus infusion of 0.9% NaCl or five equisodi

80 osmotic absorption rates induced by a fixed intravenous bolus infusion of albumin and from the capil

81 d 458 nm wavelengths, in the first 5 h after intravenous bolus infusion of benzoporphyrin derivative

82 f rest; leucovorin 30 mg/m2 administered via intravenous bolus infusion on days 1, 8, 15, and 22, fol

83 to assess neural responses during randomized intravenous bolus infusions of isoproterenol (0.5 and 2.

84 rmed by using an endocavitary probe after an intravenous bolus injection (0.04 mL/kg) and infusion (0

85 on followed by 425 mg/m2 of fluorouracil via intravenous bolus injection administered 1 to 5 days eve

86 kinetics of (13)N-nitrogen ((13)NN) after an intravenous bolus injection during a breath-hold period

87 ents to receive 20 mg/m2 of folinic acid via intravenous bolus injection followed by 425 mg/m2 of flu

88 t 1 received 50 mug/kg per day by outpatient intravenous bolus injection for 5 days of each week duri

89 ction, followed by fluorouracil, 425 mg/m(2) intravenous bolus injection given 1-5 days every 28 days

90 alog whose potency and duration of action on intravenous bolus injection in diabetic rats are indisti

91 40-min chest scans were started just before intravenous bolus injection of (18)F-LMI1195.

92 The protocol used a whole-body PET scanner, intravenous bolus injection of 1,110-1,850 MBq H(2)(15)O

93 from 20 s before to 3 min after a peripheral intravenous bolus injection of 2.5 g Levovist.

94 ans were performed concurrently with a rapid intravenous bolus injection of 232 +/- 82 MBq of (18)F-F

95 .5-8 min) were acquired over 90 min after an intravenous bolus injection of 370 MBq of tracer.

96 s, 2 hours, 1 day, and 3 days after a single intravenous bolus injection of 80 micromol of MION-47 pe

97 27-36 kg/m(2) (overweight/obese) received an intravenous bolus injection of [1,1,2,3,3-(2)H5]glycerol

98 In conclusion, intravenous bolus injection of anandamide evokes a consi

99 anaesthetized, spontaneously breathing rats, intravenous bolus injection of anandamide near the right

100 Patients received an intravenous bolus injection of cyclosporine, 2.5 mg/kg,

101 The intravenous bolus injection of E. coli endotoxin elevate

102 In contrast, an intravenous bolus injection of endotoxin (LD50 of E. col

103 During intravenous bolus injection of gadopentetate dimeglumine

104 venous, and 3-5-minute delayed phases after intravenous bolus injection of gadopentetate dimeglumine

105 We found that an intravenous bolus injection of human kallistatin caused

106 an the global layers and stain earlier after intravenous bolus injection of paramagnetic MRI contrast

107 riboflavin doses (20, 40, and 60 mg) and one intravenous bolus injection of riboflavin (11.6 mg).

108 giogram that is routinely performed with the intravenous bolus injection of the radiopharmaceutical f

109 The intravenous bolus injection technique was used in the ca

110 After intravenous bolus injection, (18)F-MNI-444 rapidly enter

111 plus folinic acid (folinic acid, 20 mg/m(2), intravenous bolus injection, followed by fluorouracil, 4

112 .3, or 1 mg/kg/day FTY720 delivered daily by intravenous bolus injection.

113 genous Ang II was administered as sequential intravenous bolus injections (2.5 to 30 ng/kg) titrated

114 ice for five weeks with once every-other-day intravenous bolus injections of apo A-I(M)/PC restored e

115 nosis of a single coronary artery were given intravenous bolus injections of BR14 during coronary hyp

116 h oral tamoxifen 20 mg daily or six 3-weekly intravenous bolus injections of cyclophosphamide 600 mg,

117 hepatomas and in 12 rabbits before and after intravenous bolus injections of SHU 563A (0.16-0.48 mL/k

118 lly long half-life of 2.3 h when injected by intravenous bolus into rabbits.

119 tranexamic acid group received 1 g in 100-mL intravenous bolus loading dose, followed by 1 g in 250-m

120 sitron-emission tomography and the O15 water intravenous bolus method to measure regional cerebral bl

121 After 4 h of feeding, an intravenous bolus of (2)H5-glycerol was administered to

122 ban dose selected at interim analysis was an intravenous bolus of 0.080 mg/kg followed by an infusion

123 atients were randomized to receive either an intravenous bolus of 0.5 mg/kg per 12 hours of methylpre

124 plasminogen activator and were also given an intravenous bolus of 0.5 or 2.0 mg/kg rhuMAb CD18 or pla

125 All patients received a single intravenous bolus of 10 mg of ICG 24 hours prior to surg

126 mboplastin time at 10 minutes after a single intravenous bolus of 15, 30, 50, and 75 mg RB006 was 29.

127 of carbidopa orally followed in 1 hour by an intravenous bolus of 150 mg of stable isotope-labeled LD

128 proximately 6.5 mmol/l in all groups, and an intravenous bolus of 2-deoxy[(3)H]glucose and [(125)I]-1

129 Instrumented rats were given an intravenous bolus of 20 mg/kg bupivacaine to induce asys

130 A single intravenous bolus of 25 microgram/kg of rhIL-10 does not

131 1 years; age range, 19-84 years) received an intravenous bolus of 25 micromol/kg Gd-EOB-DTPA and unde

132 g/kg subcutaneously every 12 hours+/-initial intravenous bolus of 30 mg).

133 del from dynamic PET scans obtained after an intravenous bolus of 62Cu-PTSM in 10 healthy volunteers

134 butamine stress echocardiography by using an intravenous bolus of a perfluorocarbon-filled, albumin-(

135 n secretion (IS) in response to a subsequent intravenous bolus of arginine, leucine, or glibenclamide

136 re distributed in 3 arms (A): A1 received an intravenous bolus of atorvastatin during MI; A2 received

137 s with relapsed myeloma to receive either an intravenous bolus of bortezomib (1.3 mg per square meter

138 An intravenous bolus of bortezomib was administered twice w

139 were taken before and at intervals after an intravenous bolus of CsA (10 mg/kg).

140 ministered as a continuous infusion, with an intravenous bolus of cyclophosphamide and oral prednison

141 Fifteen volunteers received an intravenous bolus of d9-THC and four received placebo.

142 patients with ST-elevation-MI to receive an intravenous bolus of DFO (500 mg) immediately before PPC

143 Here we investigated the effects of an acute intravenous bolus of DHA delivered after SCI and charact

144 nfection were randomized to receive a single intravenous bolus of either 25 microg/kg of recombinant

145 rfusion with primary or rescue PCI, a single intravenous bolus of epoetin alfa within 4 hours of PCI

146 e pulmonary arterial phase at the time of an intravenous bolus of gadolinium.

147 eplete their plasma FFA pool, followed by an intravenous bolus of glucose.

148 e colloid osmotic pressure following a fixed intravenous bolus of human albumin was analyzed, first b

149 rabine (100 mg/m(2) per day on days 1-7) and intravenous bolus of idarubicin (12 mg/m(2) per day on d

150 easured the hemodynamic response to a single intravenous bolus of milrinone (50 micrograms/kg body we

151 An intravenous bolus of milrinone can be used to test for t

152 ial infarction, we demonstrate that a single intravenous bolus of n-apo AI (CSL111, 80 mg/kg) deliver

153 A single intravenous bolus of n-apo AI delivered immediately post

154 and sex-matched normal subjects received an intravenous bolus of placebo and pentagastrin.

155 se in temperature, or both received a single intravenous bolus of placebo or raxibacumab at a dose of

156 ents to receive an MRA regimen with a single intravenous bolus of potassium canrenoate (200 mg) follo

157 dministration of placebo and the other by an intravenous bolus of propofol (0.75 mg/kg in one group a

158 nant mice (n=54) were injected with a single intravenous bolus of purified IgG containing human anti-

159 the last blood sample, patients received an intravenous bolus of ranitidine (0.5 mg/kg) followed by

160 e randomly assigned (1:1) to either a single intravenous bolus of tenecteplase 0.25 mg per kg of body

161 Rats were treated with an intravenous bolus of the A(1)R agonist 2-chloro-N(6)-cyc

162 p were randomly assigned to receive a single intravenous bolus of the selective vasopressin type 2 re

163 ndergoing cardiac surgery on CPB received an intravenous bolus of TP10 (1, 3, 5, 10 mg/kg) or placebo

164 us of atorvastatin during MI; A2 received an intravenous bolus of vehicle during MI; and A3 received

165 id artery balloon denudation and received an intravenous bolus of vehicle or 5, 10, 15, or 20 microgr

166 arate days a vehicle control and incremental intravenous boluses of a (P)RR antagonist, ovine handle

167 Piglets were block-randomized to receive intravenous boluses of cyclosporine A (2.5, 10, or 25 mg

168 with pacing-induced HF received incremental intravenous boluses of PDE9-I (30, 100, and 300 mg PF-04

169 NF group) at the initial dose of 2 mg/day or intravenous boluses of terlipressin (TERLI-BOL group) at

170 ethotrexate was administered as a 15 mg/m(2) intravenous bolus on day 1 and 10 mg/m(2) intravenous bo

171 method to either doxorubicin (75 mg/m(2) by intravenous bolus on day 1 or 72 h continuous intravenou

172 ded the administration of a 400 mg/m(2) 5-FU intravenous bolus on days 1 and 15; mFOLFOX6-2 omitted t

173 oma treated with bortezomib 1.0 or 1.3 mg/m2 intravenous bolus on days 1, 4, 8, and 11, every 21 days

174 2) intravenous bolus on day 1 and 10 mg/m(2) intravenous bolus on days 3, 6, and 11 after HCT; tacrol

175 es; bortezomib (1.3 mg/m(2)) was given as an intravenous bolus or subcutaneous injection on days 1, 4

176 venous infusion) or bortezomib (1.3 mg/m(2); intravenous bolus or subcutaneous injection) and dexamet

177 assigned to receive bortezomib (1.3 mg/m(2) intravenous bolus) or no bortezomib for 1 year, in combi

178 ndomly assigned (1:1) to ketamine (0.5 mg/kg intravenous bolus) or saline adjunctive to the anaesthet

179 /hr throughout reperfusion), MK-801 (5 mg/kg intravenous bolus), or CGS 19755 (40 mg/kg intravenous b

180 ubcutaneously every 12 hours+/-initial 30 mg intravenous bolus), or half-dose TNK plus abciximab and

181 was usually administered as an intermittent intravenous bolus, outside of a protocol, and was assess

182 -finding trial of rh-Endo administered as an intravenous bolus over a 20-minute period once daily.

183 be able to replace the currently recommended intravenous bolus plus infusion PPI therapy in patients

184 Intravenous bolus plus infusion proton pump inhibitor (P

185 infusion for 3 days) plus heparin (150 IU/kg intravenous bolus) plus acetyl salicylic acid (ASA) (325

186 I regimen plus ASA and 3) heparin (150 IU/kg intravenous bolus) plus ASA.

187 erpreted as acute rejection, we administered intravenous bolus steroids to five patients with BK viru

188 rejection and were treated successfully with intravenous bolus steroids.

189 After intravenous bolus synthetic human ghrelin (0.33 mug/kg)

190 .08 U/kg body wt human regular insulin as an intravenous bolus to produce moderate self-limited hypog

191 tumors is 1.2 mg/m2/dose, administered as an intravenous bolus twice weekly for 2 weeks followed by a

192 oxia time after a simulated fentanyl 2.97-mg intravenous bolus was 4.5 minutes (IQR, 2.1-infinity min

193 Supplemental analgesia (morphine or fentanyl intravenous boluses) was administered as needed before a

194 ized to receive vinblastine (V) 4 mg/m(2) by intravenous bolus weekly for 6 weeks followed by 2 weeks

195 FU was given as a rapid intravenous bolus weekly for 6 weeks with a 2-week rest.

196 and leucovorin (20 mg per square meter as an intravenous bolus) weekly for four weeks every six weeks

197 Intravenous boluses were administered at admission in 12

198 ication after the administration of a single intravenous bolus when the left ventricular cavity contr

199 the NP receptor antagonist HS-142-1 (3 mg/kg intravenous bolus) while the remaining 6 dogs received a

200 rubicin-containing chemotherapy (given as an intravenous bolus) with or without ICRF-187.